Volume 3, Issue 3
Editorialp. 175-177
Antibody immunogenicity: does bioprocessing hold all the answers?
Author(s): Herman Waldmann
Commentaryp. 179-183
Toward a two-tier process-development paradigm: prototype versus commercial biomanufacturing
Author(s): Jesus Zurdo
Research Articlep. 185-197
Automated disposable small-scale bioreactor for high-throughput process development: implementation of the 24 bioreactor array
Author(s): Rachel Bareither, Marina Goldfeld, Chris Kistler, Andrew Tait, Neil Bargh, Robert Oakeshott, Kristin ONeill, Linda Hoshan and David Pollard*
Perspective Articlep. 199-213
Exploring standards for industrializing human induced pluripotent stem cells
Author(s): Hidemasa Kato*, Keiko Hiraki-Kamon, Masamitsu Eitoku, Hidenori Kiyosawa, Cindy Neeley & Yasushi Okazaki
Review Articlep. 215-226
Development of protein-free medium for therapeutic protein production in mammalian cells: recent advances and perspectives
Author(s): Wai Lam Ling
Review Articlep. 227-247
Noncoding RNAs, post-transcriptional RNA operons and Chinese hamster ovary cells
Author(s): Fabian Stiefel, Simon Fischer, Matthias Hackl, Rene Handrick, Friedemann Hesse, Nicole Borth, Kerstin Otte and Johannes Grillari*
Review Articlep. 249-261
Glutamine substitution: the role it can play to enhance therapeutic protein production
Author(s): Tae Kwang Ha & Gyun Min Lee*
Review Articlep. 263-279
Multimodal chromatography: debottlenecking the downstream processing of monoclonal antibodies
Author(s): Ines F Pinto, Maria Raquel Aires-Barros & Ana M Azevedo*,